Literature DB >> 30053970

Respiratory care in familial dysautonomia: Systematic review and expert consensus recommendations.

Mikhail Kazachkov1, Jose-Alberto Palma2, Lucy Norcliffe-Kaufmann2, Bat-El Bar-Aluma3, Christy L Spalink2, Erin P Barnes2, Nancy E Amoroso4, Stamatela M Balou5, Shay Bess6, Arun Chopra7, Rany Condos4, Ori Efrati3, Kathryn Fitzgerald8, David Fridman4, Ronald M Goldenberg4, Ayelet Goldhaber9, David A Kaufman4, Sanjeev V Kothare10, Jeremiah Levine9, Joseph Levy9, Anthony S Lubinsky4, Channa Maayan11, Libia C Moy9, Pedro J Rivera4, Alcibiades J Rodriguez12, Gil Sokol3, Mark F Sloane4, Tina Tan13, Horacio Kaufmann14.   

Abstract

BACKGROUND: Familial dysautonomia (Riley-Day syndrome, hereditary sensory autonomic neuropathy type-III) is a rare genetic disease caused by impaired development of sensory and afferent autonomic nerves. As a consequence, patients develop neurogenic dysphagia with frequent aspiration, chronic lung disease, and chemoreflex failure leading to severe sleep disordered breathing. The purpose of these guidelines is to provide recommendations for the diagnosis and treatment of respiratory disorders in familial dysautonomia.
METHODS: We performed a systematic review to summarize the evidence related to our questions. When evidence was not sufficient, we used data from the New York University Familial Dysautonomia Patient Registry, a database containing ongoing prospective comprehensive clinical data from 670 cases. The evidence was summarized and discussed by a multidisciplinary panel of experts. Evidence-based and expert recommendations were then formulated, written, and graded using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system.
RESULTS: Recommendations were formulated for or against specific diagnostic tests and clinical interventions. Diagnostic tests reviewed included radiological evaluation, dysphagia evaluation, gastroesophageal evaluation, bronchoscopy and bronchoalveolar lavage, pulmonary function tests, laryngoscopy and polysomnography. Clinical interventions and therapies reviewed included prevention and management of aspiration, airway mucus clearance and chest physical therapy, viral respiratory infections, precautions during high altitude or air-flight travel, non-invasive ventilation during sleep, antibiotic therapy, steroid therapy, oxygen therapy, gastrostomy tube placement, Nissen fundoplication surgery, scoliosis surgery, tracheostomy and lung lobectomy.
CONCLUSIONS: Expert recommendations for the diagnosis and management of respiratory disease in patients with familial dysautonomia are provided. Frequent reassessment and updating will be needed.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Keywords:  Aspiration pneumonia; Chemoreflex failure; Neurogenic dysphagia; Non-cystic fibrosis bronchiectasis; Rare neurological disorders

Mesh:

Year:  2018        PMID: 30053970      PMCID: PMC6084453          DOI: 10.1016/j.rmed.2018.06.017

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  90 in total

1.  GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.

Authors:  Gordon H Guyatt; Andrew D Oxman; Gunn E Vist; Regina Kunz; Yngve Falck-Ytter; Pablo Alonso-Coello; Holger J Schünemann
Journal:  BMJ       Date:  2008-04-26

2.  Short-term recombinant human DNase in bronchiectasis. Effect on clinical state and in vitro sputum transportability.

Authors:  P J Wills; T Wodehouse; K Corkery; K Mallon; R Wilson; P J Cole
Journal:  Am J Respir Crit Care Med       Date:  1996-08       Impact factor: 21.405

3.  Postoperative complications after Nissen fundoplication.

Authors:  Sv Toshev; G Todorov; M Sokolov; G Velev; K Angelov; P Gribnev; A Koichev; N Haiat
Journal:  Khirurgiia (Sofiia)       Date:  2014

4.  Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. rhDNase Study Group.

Authors:  A E O'Donnell; A F Barker; J S Ilowite; R B Fick
Journal:  Chest       Date:  1998-05       Impact factor: 9.410

5.  Neonatal recognition of familial dysautonomia.

Authors:  F B Axelrod; R F Porges; M E Sein
Journal:  J Pediatr       Date:  1987-06       Impact factor: 4.406

6.  Orthopaedic defects in familial dysautonomia. A review of sixty-five cases.

Authors:  W Yoslow; M H Becker; J Bartels; W A Thompson
Journal:  J Bone Joint Surg Am       Date:  1971-12       Impact factor: 5.284

Review 7.  Sleep-disordered breathing and hormones.

Authors:  T Saaresranta; O Polo
Journal:  Eur Respir J       Date:  2003-07       Impact factor: 16.671

8.  Brainstem reflexes in patients with familial dysautonomia.

Authors:  Joel V Gutiérrez; Lucy Norcliffe-Kaufmann; Horacio Kaufmann
Journal:  Clin Neurophysiol       Date:  2014-07-03       Impact factor: 3.708

9.  Onabotulinum toxin A for the treatment of sialorrhea in familial dysautonomia.

Authors:  Sam J Daniel; Isabel Cardona
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2014-02-15       Impact factor: 1.675

10.  Neurogenic dysphagia with undigested macaroni and megaesophagus in familial dysautonomia.

Authors:  Jose-Alberto Palma; Christy Spalink; Erin P Barnes; Lucy Norcliffe-Kaufmann; Horacio Kaufmann
Journal:  Clin Auton Res       Date:  2017-12-01       Impact factor: 4.435

View more
  3 in total

Review 1.  Hereditary Sensory and Autonomic Neuropathies: Adding More to the Classification.

Authors:  Coreen Schwartzlow; Mohamed Kazamel
Journal:  Curr Neurol Neurosci Rep       Date:  2019-06-20       Impact factor: 5.081

Review 2.  Chemoreflex failure and sleep-disordered breathing in familial dysautonomia: Implications for sudden death during sleep.

Authors:  Jose-Alberto Palma; Alex Gileles-Hillel; Lucy Norcliffe-Kaufmann; Horacio Kaufmann
Journal:  Auton Neurosci       Date:  2019-02-15       Impact factor: 3.145

Review 3.  Conservative Treatment or Surgical Treatment: A Case Report and Literature Review of Multiple Fractures of the Lower Extremities in a Child with Insensitivity to Pain.

Authors:  Yi-Kang Yu; Dong-Peng Tu; Xiao-Lin Shi; Zheng Liu; Xin Fan; Chao Xu
Journal:  Orthop Surg       Date:  2020-04-19       Impact factor: 2.071

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.